AP9901515A0 - Reagent system and kit or detecting HIV infected cells. - Google Patents
Reagent system and kit or detecting HIV infected cells.Info
- Publication number
- AP9901515A0 AP9901515A0 APAP/P/1999/001515A AP9901515A AP9901515A0 AP 9901515 A0 AP9901515 A0 AP 9901515A0 AP 9901515 A AP9901515 A AP 9901515A AP 9901515 A0 AP9901515 A0 AP 9901515A0
- Authority
- AP
- ARIPO
- Prior art keywords
- cells
- present
- infected cells
- relates
- kit
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
- G01N33/54326—Magnetic particles
- G01N33/54333—Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- AIDS & HIV (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
This invention related to blood collection and diagnostics. More particularly, the invention relates to blood collection and diagnostics utilizing techniques such as magnetic separation and photodetection. The present invention also relates to methods and an apparatus for detecting the presence of antigens displayed on the surface of cells. More preferably, the present invention relates to the detection of cells infected by human immunodeficiency virus (hiv)and related viruses. In accordance with the present invention, hiv-infected cells can be detected and separated from uninfected cells. In a preferred embodiment, separation is achieved by a magnetic field. By coating the infected cells with magnetic particles, transfer of the cells to a precise location is facilitated. A novel aspect os the present invention is a cartridge antigen test which allows for the collection and mixing of blood with reagents in one package, which can be viewed on a fluoresent microscope.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/732,784 US5714390A (en) | 1996-10-15 | 1996-10-15 | Cartridge test system for the collection and testing of blood in a single step |
US08/732,782 US5817458A (en) | 1996-10-15 | 1996-10-15 | Reagent system for detecting HIV-infected peripheral blood lymphocytes in whole blood |
PCT/US1997/018649 WO1998016101A1 (en) | 1996-10-15 | 1997-10-15 | Reagent system and kit for detecting hiv infected cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AP9901515A0 true AP9901515A0 (en) | 1999-06-30 |
Family
ID=27112456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1999/001515A AP9901515A0 (en) | 1996-10-15 | 1997-10-15 | Reagent system and kit or detecting HIV infected cells. |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0933989A1 (en) |
JP (1) | JP2001503859A (en) |
AP (1) | AP9901515A0 (en) |
AU (1) | AU743937B2 (en) |
WO (1) | WO1998016101A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010039007A1 (en) * | 1996-10-15 | 2001-11-08 | Robert Hallowitz | Methods and compositions for determining latent viral load |
WO2002003064A1 (en) * | 2000-06-30 | 2002-01-10 | Bio-Tech Imaging, Inc. | Methods for characterizing the viral infectivity status of a host |
FR2832507B1 (en) | 2001-11-20 | 2004-02-20 | Stago Diagnostica | METHOD OF DETECTING ANALYTE (S) USING COLLOIDAL MAGNETIC PARTICLES |
ATE521640T1 (en) * | 2002-10-01 | 2011-09-15 | Functional Genetics Inc | ANTI-TSG101 ANTIBODIES AND THEIR USES IN THE TREATMENT OF VIRUS INFECTIONS |
EP1771736A4 (en) * | 2004-07-20 | 2008-08-13 | Cgk Co Ltd | System for detecting molecular interactions |
CN107290534A (en) * | 2017-07-12 | 2017-10-24 | 华讯方舟科技有限公司 | A kind of blood cell capture chip and method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4659678A (en) * | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
FI844027A (en) * | 1984-10-12 | 1986-04-13 | Labsystems Oy | IMMUNOLOGISKT BESTAEMNINGSFOERFARANDE. |
DE68919715T2 (en) * | 1988-12-28 | 1995-04-06 | Stefan Miltenyi | METHOD AND MATERIALS FOR HIGHLY GRADUATED MAGNETIC SPLITTING OF BIOLOGICAL MATERIALS. |
US5054499A (en) * | 1989-03-27 | 1991-10-08 | Swierczek Remi D | Disposable skin perforator and blood testing device |
US5541072A (en) * | 1994-04-18 | 1996-07-30 | Immunivest Corporation | Method for magnetic separation featuring magnetic particles in a multi-phase system |
US5231993A (en) * | 1991-11-20 | 1993-08-03 | Habley Medical Technology Corporation | Blood sampler and component tester with guide member |
-
1997
- 1997-10-15 AP APAP/P/1999/001515A patent/AP9901515A0/en unknown
- 1997-10-15 AU AU48224/97A patent/AU743937B2/en not_active Ceased
- 1997-10-15 JP JP51858298A patent/JP2001503859A/en active Pending
- 1997-10-15 WO PCT/US1997/018649 patent/WO1998016101A1/en not_active Application Discontinuation
- 1997-10-15 EP EP97910976A patent/EP0933989A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2001503859A (en) | 2001-03-21 |
EP0933989A1 (en) | 1999-08-11 |
WO1998016101A1 (en) | 1998-04-23 |
AU743937B2 (en) | 2002-02-07 |
AU4822497A (en) | 1998-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Constantine et al. | HIV testing technologies after two decades of evolution | |
CA2272881C (en) | Assay method for peptide specific t-cells | |
McHugh et al. | Simultaneous detection of antibodies to cytomegalovirus and herpes simplex virus by using flow cytometry and a microsphere-based fluorescence immunoassay | |
US7129056B2 (en) | Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood | |
AU655592B2 (en) | Hepatitis C assay utilizing recombinant antigens | |
AP9901515A0 (en) | Reagent system and kit or detecting HIV infected cells. | |
Böni et al. | Sensitive detection and quantification of particle‐associated reverse transcriptase in plasma of HIV‐1‐infected individuals by the product‐enhanced reverse transcriptase (PERT) assay | |
EP0902286A2 (en) | Immunoassay utilizing two incubations with labelled antigen | |
CA2303123A1 (en) | Method for detecting antibodies in a sample | |
WO1995023973A3 (en) | Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents | |
Lyamuya et al. | Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults | |
Soroka et al. | The use of simple, rapid tests to detect antibodies to human immunodeficiency virus types 1 and 2 in pooled serum specimens | |
ES2094124T3 (en) | IMMUNOLOGICAL TEST OF ANTIBODIES AGAINST HIV. | |
Tobery et al. | Identification of T-cell epitopes using ELISpot and peptide pool arrays | |
Vallari et al. | Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 | |
RU97115554A (en) | DETECTION OF ANTIBODY PRODUCTION | |
Mas et al. | Reliability of a new recombinant immunoblot assay (RIBA HIV-1/HIV-2 SIA) as a supplemental (confirmatory) test for HIV-1 and HIV-2 infections | |
Asihene et al. | Evaluation of rapid test for detection of antibody to human immunodeficiency virus type 1 and type 2 | |
Sommerfelt et al. | A simple semi-rapid HIV-1&2 confirmatory immunoassay using magnetic particles | |
CA2116026A1 (en) | Hepatitis c assay utilizing recombinant antigens to c-100 region | |
RU2002100350A (en) | Antibody analysis | |
Sirivichayakul et al. | Evaluation of a 2-minute anti-human immunodeficiency virus (HIV) test using the autologous erythrocyte agglutination technique with populations differing in HIV prevalence | |
RU2234700C2 (en) | Method for diagnosis of viral hepatitis b | |
Delaporte et al. | Interpretation of antibodies reacting solely with human retroviral core proteins in western equatorial Africa | |
Elavia et al. | Performance evaluation of a particle agglutination test for antibody to human immunodeficiency virus 1: comparison with enzyme immunoassay |